PharmaTelevision - Joaquin Gomez of Ingeniatrics discusses their Flow Focusing and Flow Blurring technology

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Joaquin Gomez of Ingeniatrics discusses their Flow Focusing and Flow Blurring technology

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Joaquin Gomez, CEO at Ingeniatrics

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Technology and Application areas

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here from BioPharm America in Boston. On this show I have Joaquin Gomez Moya , who is CEO of a company called Ingeniatrics , which is based in Seville, in Spain, welcome to the show.

Joaquin Gomez Moya:

Good morning.

Fintan Walton:

Good morning to you. Tell me little bit about your company and the technology it has.

Joaquin Gomez Moya:

Well, Ingeniatrics was founded by Alfonso Ganan-Calvo who was the discoverer of Flow-Focusing phenomenon, first discoverer the axisymmetrical Flow-Focusing for those formula with the microfluidics. Alfonso Ganan-Calvo is a full professor in the University of Seville, then he thought that he could make Ingeniatrics to market solutions applying this technology Flow-Focusing and all the microfluidics phenomenon with similar mathematical, geometrical configuration Flow-Blurring, ElectroFlow-Focusing, ConcentricFlow-Focusing.

Fintan Walton:

Right, so that was the that's the basis of the company that capability, that technology that's embedded in the company, so how do you apply that into the pharmaceutical industry?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Joaquin Gomez Moya

Chief Executive Officer

Joaquin Gomez Moya currently holds the position of CEO at Ingeniatrics Tecnologias , COO / Director de Operaciones at Ingeniatrics Global LLC, Voting Trustee Observer at Ingeniatrics . In the past Joaquin Gomez Moya had served as General Manager Director General at Vinispana, University lecturer at UCLM, Managing Director Director Gerente at Invencible, Sales Account. Joaquin Gomez Moya completed his education from University of Cambridge, ESDEN, Escuela de Organizaci"n Industrial, IEDE Institute for Executive Development and Universidad Nacional de Educacion.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

Ingeniatrics Tecnologias

Ingeniatrics Tecnologias is a privately owned technology-based company (TBC), created in 2001 by a team of biotech entrepreneurs and researchers from the University of Seville. Ingeniatrics born in response to the idea of developing a vehicle to implement diverse applications of Technology Platform that comprises a bundle of technologies allows the differential handling of a wide variety of fluids. Ingeniatrics Tecnologias is a technology-based company (TBC) with over 50 patents and applications nationally and internationally, in Flow-Focusing and Flow-Blurring micro and nanoscale production technologies of aerosols, particles, emulsions and microencapsulation. Ingeniatrics Tecnologias mission is to offer technically innovative products and services, with high added value and sustainability like OneNeb, Frialia, Cell-ENA, Flow-Focusing microencapsulation services. Our vision focuses on maximizing and implementing our expertise in microfluidic technologies.